摘要
透明质酸(HA)是一种相对较新的药物传递系统的结构。CD44和HA运动介导的受体在内吞作用时发挥关键作用。通过利用HA作为药物载体,细胞摄取和肿瘤靶向给药的效率可以增加。目前,HA为物理封装或与各种药物化学共轭提供了有效的平台。在这篇综述中,我们总结了HA最新的研究进展,并对基于HA药物输送系统的应用前景进行了讨论。
关键词: CD44,化学改性,偶联物,衍生物,透明质酸,纳米载体。
图形摘要
Current Drug Targets
Title:Advances in Hyaluronic Acid-Based Drug Delivery Systems
Volume: 17 Issue: 6
Author(s): Yan Jiao, Xin Pang and Guangxi Zhai
Affiliation:
关键词: CD44,化学改性,偶联物,衍生物,透明质酸,纳米载体。
摘要: Hyaluronic acid (HA) is a relatively new polymer for the construction of drug delivery systems. CD44 and the receptor for HA-mediated motility play a key role in vivo for the receptormediated endocytosis of HA. Cellular uptake and the efficiency of tumor-targeted drug delivery are supposed to increase through utilizing HA as drug carriers. Currently, HA has provided a promising platform to physically encapsulate or chemically conjugate with various drugs. In this review, we presented the most latest advances in HA-based drug delivery systems and some forward-looking ideas are discussed.
Export Options
About this article
Cite this article as:
Yan Jiao, Xin Pang and Guangxi Zhai , Advances in Hyaluronic Acid-Based Drug Delivery Systems, Current Drug Targets 2016; 17 (6) . https://dx.doi.org/10.2174/1389450116666150531155200
DOI https://dx.doi.org/10.2174/1389450116666150531155200 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sentinel Lymph Node Mapping in Early Stage Endometrial Cancer Patients in Low-Resource Settings
Current Women`s Health Reviews Diabetes Mellitus as a Risk Factor for Cancer: Stress or Viral Etiology?
Infectious Disorders - Drug Targets The Biological Functions of NF-κB1 (p ) and its Potential as an Anti-Cancer Target
Current Cancer Drug Targets Detection of Fungal Infections Using Radiolabeled Antifungal Agents
Current Drug Targets Different Gene Therapy Strategies: A Overview for Prostate Cancer
Current Gene Therapy Toll-Like Receptors in Alzheimer's Disease: A Therapeutic Perspective
CNS & Neurological Disorders - Drug Targets Clinical Proteomics in Cancer Research
Current Proteomics Investigation of in Vitro Release Dynamics of Cisplatin from Genipin Crosslinked Gelatin Nanocarriers
Drug Delivery Letters Anti-Genes: siRNA, Ribozymes and Antisense
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member:
Current Pharmaceutical Design Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects
Recent Patents on Anti-Cancer Drug Discovery Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
Current Cancer Drug Targets Issues Impacting Therapeutic Outcomes in Pediatric Patients: An Overview
Current Pediatric Reviews Biocatalysis in the Pharmaceutical Industry. A Greener Future
Current Green Chemistry Metabotropic Glutamate Receptors in Central Nervous System Diseases
Current Drug Targets HGF and RhoGTPases in Cancer Cell Motility
Current Signal Transduction Therapy Network Medicine and High Throughput Screening
Current Drug Discovery Technologies Noteworthy Secondary Metabolites Naphthoquinones – their Occurrence, Pharmacological Properties and Analysis
Current Pharmaceutical Analysis Protective Mechanisms of Helminths Against Reactive Oxygen Species are Highly Promising Drug Targets
Current Medicinal Chemistry Antitumor Activities of Interleukin-27 on Melanoma
Endocrine, Metabolic & Immune Disorders - Drug Targets